IP Verse

Revitope competitive analysis

Loading summary...

Latest oppositions filed by Revitope

Explore patent oppositions filed by Revitope against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2802607
Dual Antigen-Induced Bipartite Functional ComplementationJULIUS MAXIMILIANS UNIVERSITT WRZBURGJul 3, 2018

Latest patents of Revitope opposed by its competitors

Explore Revitope's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3377103
Mar 12, 2025Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted Cells2

Latest publications and patents of Revitope New

Explore the latest publications and patents granted to Revitope, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Revitope

EP3377103
Mar 12, 2025Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted CellsPatent Maintained As Amended

Latest PTAB cases involving Revitope

Discover the latest PTAB cases involving Revitope, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Revitope with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
REVITOPE12 - -
CHERRY BIOLABS1 - - -
JULIUS MAXIMILIANS UNIVERSITT WRZBURG - 4 - -
TAKEDA PHARMACEUTICAL121 - 1